Scaling the Andean Shilajit: A Novel Neuroprotective Agent for Alzheimer’s Disease

Alzheimer’s disease (AD) is a multifactorial neurodegenerative disorder without a cure, despite the enormous number of investigations and therapeutic approaches. AD is a consequence of microglial responses to “damage signals”, such as aggregated tau oligomers, which trigger a neuro-inflammatory reac...

Full description

Bibliographic Details

Main Authors:	Víctor Andrade, Maylin Wong-Guerra, Nicole Cortés, Gabriela Pastor, Andrea González, Camila Calfío, Leonardo Guzmán-Martínez, Leonardo P. Navarrete, Nicolas Ramos-Escobar, Inelia Morales, Rocío Santander, Juan Andrades-Lagos, Mitchell Bacho, Leonel E. Rojo, Ricardo Benjamín Maccioni
Format:	Artigo
Language:	Inglês
Published:	MDPI AG 2023-07-01
Series:	Pharmaceuticals
Subjects:	Alzheimer’s disease (AD) Andean Shilajit (AnSh) bioactive fractions molecular networks neuroprotector prevalent neurological disorders
Online Access:	https://www.mdpi.com/1424-8247/16/7/960
Tags:	Add Tag No Tags, Be the first to tag this record!